IMS brochure

Using real-world data to find undiagnosed patients with rare diseases

In Clinical Development, Orphan Drug Congress, Orphan Drugs Live by Freya SmaleLeave a Comment

April 20, 9:00am – 12:00pm | Pre-Conference Workshop
IMS Health Real-World Evidence Solutions presents: Using real-world data to find undiagnosed patients with rare diseases

Download the IMS Health Workshop brochure for a sneak preview of their session >

Under-diagnosis is a major barrier to the successful treatment of rare diseases. New tools leveraging real-world data and innovation in advanced analytics are creating opportunities for dramatic improvements in identifying hard-to-find patients. The purpose of this workshop is to explore the ways in which real-world data (RWD) can be used to address the problem of under-diagnosis in rare diseases. The session will illustrate how companies worldwide are breaking new ground in understanding rare diseases through a variety of case studies. It will also include innovative ideas on how to build new engagement models with providers and payers to increase rare disease treatments. Expect a highly interactive session with opportunity for audience members to ask questions and share their experience.

Download the IMS Health Workshop brochure for more information >

Speakers:
Michel Denarié, MBA, Senior Principal, RWE Solutions, IMS Health
Nadea Leavitt, MSC, Engagement Manager, RWE Solutions, IMS Health
Leanne Li, MBA, Engagement Manager, RWE Solutions, IMS Health
Kelly Peters, VP, Customer Segments, RWE Solutions & Commercial Services, IMS Health
Dr John Rigg, PhD, Principal and Head of Predictive Analytics, IMS Health
Diana Wong, MBA, MSC, BSC, Principal, RWE Solutions, IMS Health

Download the IMS Health Workshop brochure for more information >

Register for the World Orphan Drug Congress USA 2016 for access to this workshop and more! Register now >

World Orphan Drug Congress USA 2016

Leave a Comment